NL1001348C2 - Polypeptide comprising glycosyl-phosphatidyl:inositol structure - Google Patents

Polypeptide comprising glycosyl-phosphatidyl:inositol structure

Info

Publication number
NL1001348C2
NL1001348C2 NL1001348A NL1001348A NL1001348C2 NL 1001348 C2 NL1001348 C2 NL 1001348C2 NL 1001348 A NL1001348 A NL 1001348A NL 1001348 A NL1001348 A NL 1001348A NL 1001348 C2 NL1001348 C2 NL 1001348C2
Authority
NL
Netherlands
Prior art keywords
polypeptide
recombinant
glycosyl
phosphatidyl
sequence
Prior art date
Application number
NL1001348A
Other languages
English (en)
Dutch (nl)
Inventor
Nicolas Joseph Fasel
Christophe Dominique Reymond
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/428,616 priority Critical patent/US6113917A/en
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Priority to IL11802196A priority patent/IL118021A0/xx
Priority to NZ335929A priority patent/NZ335929A/xx
Priority to CA002218987A priority patent/CA2218987A1/en
Priority to CZ19973378A priority patent/CZ291013B6/cs
Priority to AU56481/96A priority patent/AU714808B2/en
Priority to PL96323078A priority patent/PL323078A1/xx
Priority to BR9604989-8A priority patent/BR9604989A/pt
Priority to NZ307195A priority patent/NZ307195A/xx
Priority to PCT/EP1996/001744 priority patent/WO1996034105A1/en
Priority to EP96913528A priority patent/EP0826050A1/en
Priority to HU9802238A priority patent/HUP9802238A3/hu
Priority to JP8532179A priority patent/JPH11504215A/ja
Application granted granted Critical
Publication of NL1001348C2 publication Critical patent/NL1001348C2/xx
Priority to NO974924A priority patent/NO974924L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL1001348A 1995-04-25 1995-10-05 Polypeptide comprising glycosyl-phosphatidyl:inositol structure NL1001348C2 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity
IL11802196A IL118021A0 (en) 1995-04-25 1996-04-23 Modified polypeptides for enhanced immunogenicity
PCT/EP1996/001744 WO1996034105A1 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
CZ19973378A CZ291013B6 (cs) 1995-04-25 1996-04-25 Modifikované polypeptidy vykazující zvýąenou imunogenitu
AU56481/96A AU714808B2 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
PL96323078A PL323078A1 (en) 1995-04-25 1996-04-25 Modified polypeptides of enchanced immunogenecity
NZ335929A NZ335929A (en) 1995-04-25 1996-04-25 Use of a recombinant polypeptide having a glycosyl-phosphatidylinositol anchor for inducing an immune response
NZ307195A NZ307195A (en) 1995-04-25 1996-04-25 Recombinant polypeptides containing a glycosyl-phosphatidylinositol anchor having enhanced immunogencity against parasites
CA002218987A CA2218987A1 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
EP96913528A EP0826050A1 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
HU9802238A HUP9802238A3 (en) 1995-04-25 1996-04-25 Modified polypeptides for enhanced immunogenicity
JP8532179A JPH11504215A (ja) 1995-04-25 1996-04-25 免疫原性の高められた修飾ポリペプチド
BR9604989-8A BR9604989A (pt) 1995-04-25 1996-04-25 Polipeptídeos modificados para imunogenicidade aperfeiçoada e processo de sua produção
NO974924A NO974924L (no) 1995-04-25 1997-10-24 Modifiserte polypeptider med öket immunogenisitet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201066 1995-04-25
US08/428,616 US6113917A (en) 1995-04-25 1995-04-25 Modified polypeptides for enhanced immunogenicity

Publications (1)

Publication Number Publication Date
NL1001348C2 true NL1001348C2 (en) 1996-10-28

Family

ID=26139248

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1001348A NL1001348C2 (en) 1995-04-25 1995-10-05 Polypeptide comprising glycosyl-phosphatidyl:inositol structure

Country Status (15)

Country Link
US (1) US6113917A (cs)
EP (1) EP0826050A1 (cs)
JP (1) JPH11504215A (cs)
AU (1) AU714808B2 (cs)
BR (1) BR9604989A (cs)
CA (1) CA2218987A1 (cs)
CZ (1) CZ291013B6 (cs)
HU (1) HUP9802238A3 (cs)
IL (1) IL118021A0 (cs)
NL (1) NL1001348C2 (cs)
NO (1) NO974924L (cs)
NZ (1) NZ307195A (cs)
PL (1) PL323078A1 (cs)
WO (1) WO1996034105A1 (cs)
ZA (1) ZA963269B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504223A (ja) * 1996-01-29 2000-04-11 ジョージタウン・ユニヴァーシティ Ｍｓａ１ペブチドの付加に基づいたマラリアワクチン
AUPP589398A0 (en) * 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
KR20100039911A (ko) * 2001-10-13 2010-04-16 아스테리온 리미티드 폴리펩타이드들을 포함하는 글리코실포스파티딜이노시톨
US20030171260A1 (en) * 2002-03-11 2003-09-11 Nelson Deanna Jean Compositions and methods utilizing hydroxamates to scavenge oxidant toxins
US8038986B2 (en) 2002-07-26 2011-10-18 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and diagnostic and therapeutic uses thereof
US7625998B2 (en) 2003-04-09 2009-12-01 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol
US20080026008A1 (en) * 2006-07-27 2008-01-31 Clark Tibbs Bacteriophage DNA vaccine vector
KR20240021211A (ko) * 2021-06-10 2024-02-16 얀센 바이오테크 인코포레이티드 Klk2-gpi 융합 단백질에 대한 핵산 코딩, 재조합 세포 및 이의 용도

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020806A2 (en) * 1991-05-17 1992-11-26 Rmf Dictagene S.A. Dictyostelid expression vector and method for expressing a desired protein
WO1995022614A1 (en) * 1994-02-17 1995-08-24 Finep-Financiadora De Estudos E Projetos Production of glycosylphosphatidylinositol-anchored recombinant proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020806A2 (en) * 1991-05-17 1992-11-26 Rmf Dictagene S.A. Dictyostelid expression vector and method for expressing a desired protein
WO1995022614A1 (en) * 1994-02-17 1995-08-24 Finep-Financiadora De Estudos E Projetos Production of glycosylphosphatidylinositol-anchored recombinant proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PEARCE E. J. ET AL.: "Three major surface antigens of Schistosoma mansoni are linked to the membrane by glycosylphosphatidylinositol", JOURNAL OF IMMUNOLOGY, vol. 142, no. 3, 1 February 1989 (1989-02-01), BALTIMORE US, pages 979 - 984 *
REYMOND C D ET AL: "Anchoring of an immunogenic Plasmodium falciparum circumsporozoite protein on the surface of Dictyostelium discoideum.", JOURNAL OF BIOLOGICAL CHEMISTRY 270 (21). 1995. 12941-12947 *
VAI M ET AL: "ISOLATION AND DEDUCED AMINO ACID SEQUENCE OF THE GENE ENCODING GP115 A YEAST GLYCOPHOSPHOLIPID-ANCHORED PROTEIN CONTAINING A SERINE-RICH REGION.", J BIOL CHEM 266 (19). 1991. 12242-12248 *

Also Published As

Publication number Publication date
ZA963269B (en) 1996-10-25
US6113917A (en) 2000-09-05
CZ291013B6 (cs) 2002-11-13
HUP9802238A3 (en) 2000-03-28
HUP9802238A2 (hu) 1999-01-28
AU714808B2 (en) 2000-01-13
IL118021A0 (en) 1996-08-04
CZ337897A3 (cs) 1998-04-15
AU5648196A (en) 1996-11-18
WO1996034105A1 (en) 1996-10-31
PL323078A1 (en) 1998-03-02
NO974924D0 (no) 1997-10-24
NZ307195A (en) 1999-07-29
BR9604989A (pt) 1999-11-30
NO974924L (no) 1997-12-19
JPH11504215A (ja) 1999-04-20
EP0826050A1 (en) 1998-03-04
CA2218987A1 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
PT74811A (en) Bacillus cloning vectors recombinant dna molecules bacillus hosts transformed with them and methods for expressing foreign dna sequences and producing polypeptides coded thereby
NL1001348C2 (en) Polypeptide comprising glycosyl-phosphatidyl:inositol structure
EP1619202A3 (en) immunotherapeutic methods using epitopes of wt-1 and gata-1
IL62553A0 (en) Vectors comprising dna sequences and methods for producing recombinant dna molecules and cloning vectors
IE883612L (en) Vectors and compounds for direct expression of activated human protein c
NZ232742A (en) Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced
ZA885764B (en) Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology,process,expression vector and recombinant host therefor and pharmaceutical use thereof
ES2087323T3 (es) Metodo para producir peptidos exentos de cisteina.
IE831211L (en) Cloning vectors for expression of exogenous protein
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
ES8606494A1 (es) Un metodo de producir un peptido o polipeptido sintetico.
MX9204291A (es) Molecula de adn recombinante que codifica para la prolilendopeptidasa, vectores hibridos que contienen dicho adn, huespedes transformados capaces de expresar la prolilendopeptidasa y procedimiento para la produccion de la prolilendopeptidasa.
ES547871A0 (es) Metodo para producir la proteina factor recombinante de necrosis de tumores hermanos (tnf) a partir de celulas hospedantes competentes transformadas con un vector de expresion.
AR012499A1 (es) Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin
SE8204811L (sv) Dna-fragment innefattande en signalsekvens
AU4864997A (en) Recombinant process for preparing a complete malaria antigen, gp190/MSP1
WO1997012044A3 (en) Pichia secretory leader for protein expression
EP0146903A3 (en) Production of a vector encoding a novel hybrid interferon species
HU9300098D0 (en) Method for producing expression vector of dictyostelide and for producing protein thereby
DE3380495D1 (en) Molecular cloning and characterization of the gene sequence coding for porcine relaxin
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
WO1988006186A3 (en) cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector
NO179373C (no) Rekombinant vektor istand til å uttrykke et glykoprotein, transformant som uttrykker et glykoprotein og fremgangsmåte for fremstilling av et glykoprotein
CA2382302A1 (en) A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis

Legal Events

Date Code Title Description
PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20060501